Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified transseptal sheath.
A patient developed hemolysis and hematuria 2 d after placement of a 12 mm Rashkind PDA occlusion device. Six days after placement, the device was snared from the ductus arteriosus and removed through a modified transseptal sheath. A 17 mm PDA occlusion device was successfully placed in the PDA, with resolution of the hematuria.